Anke Wouters

Anke Wouters

Auto-generated profile, based on publicly available information

Anke Wouters

KU Leuven, Leuven Brain Institute, Department of Neurosciences, Experimental Neurology, Belgium (J.D., L.M., A.W.).

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2014 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
AWAnke Wouters
Anke Wouters
RLRobin Lemmens
Robin Lemmens
PDPatrick Dupont
Patrick Dupont
VTVincent Thijs
Vincent Thijs
Patients who wake up with an ischemic stroke, account for a large number of the total stroke population, due to circadian morning predominance of stroke. Currently, this subset of patients is excluded from revascularization-therapy since no exact time of onset is known. A large group of these patients might be eligible for therapy. In this review, we assessed the current literature about the hypothesis that wake-up strokes occur just prior on awakening and if this subgroup differs in characteristics compared to the overall stroke-population. We looked at the safety and efficacy of thrombolysis and interventional techniques in the group of patients with unknown stroke-onset. We performed a meta-analysis of the diagnostic accuracy of the diffusion-FLAIR mismatch in identifying stroke within 3 and 4.5 hours. The different imaging-selection-criteria that can be used to treat these patients are discussed. Additional research on imaging findings associated with recent stroke and penumbral imaging will eventually lead to a shift from a rigid time-frame based therapy to a tissue-based individualized treatment approach.

1 April 2016 in Stroke
Verified
Journal Article
Closed access
PDF file
AWAnke Wouters
Anke Wouters
PDPatrick Dupont
Patrick Dupont
SCSoren Christensen
Soren Christensen
BNBo Norrving
Bo Norrving
RLRico Laage
Rico Laage
RLRobin Lemmens
Robin Lemmens
Background and Purpose—: In patients with acute stroke, the intensity of a fluid-attenuated inversion recovery (FLAIR) lesion in the region of diffusion restriction is associated with time from symptom onset. We hypothesized that collateral status as assessed by the hypoperfusion intensity ratio could modify the association between time from stroke onset and FLAIR lesion intensity. Methods—: From the AX200 for ischemic stroke trial, 141 patients had appropriate FLAIR, diffusion-weighted imaging, and perfusion-weighted imaging. In the region of nonreperfused core, we calculated voxel-based relative FLAIR (rFLAIR) signal intensity. The hypoperfusion intensity ratio was defined as the ratio of the T max >10 s lesion over the T max >6 s lesion volume. A hypoperfusion intensity ratio threshold of ≤0.4 was used to dichotomize good versus poor collaterals. We studied the interaction between collateral status on the association between time from symptom onset and FLAIR intensity. Results—: Time from symptom onset was associated with the rFLAIR intensity in the region of nonreperfused core ( B =1.05; 95% confidence interval, 1.0–1.1). We identified an interaction between this association and collateral status; an association was present between time and rFLAIR intensity in patients with poor collaterals ( r =0.53), but absent in patients with good collaterals ( r =0.17; P =0.04). Conclusions—: Our findings show that the relationship between time from symptom onset and rFLAIR lesion intensity depends on collateral status. In patients with good collaterals, the development of an rFLAIR-positive lesion is less dependent on time from symptom onset compared with patients with poor collaterals.

13 October 2017 in Frontiers in Neurology
Verified
Journal Article
Open access
AWAnke Wouters
Anke Wouters
SCSøren Christensen
Søren Christensen
MSMatus Straka
Matus Straka
MMMichael Mlynash
Michael Mlynash
JLJohn Liggins
John Liggins
MLMaarten G. Lansberg
Maarten G. Lansberg
Background and Purpose: The PWI (perfusion weighted imaging) / DWI (diffusion weighted imaging) mismatch profile is used to select patients for endovascular treatment. A PWI map of Tmax is commonly used to identify tissue with critical hypoperfusion. A time to peak (TTP) map reflects similar hemodynamic properties with the added benefit that it does not require AIF selection and deconvolution. We aimed to determine if TTP could substitute Tmax for mismatch categorization. Methods: Imaging data of the DEFUSE 2 trial were reprocessed to generate relative TTP (rTTP) maps. We identified the rTTP threshold that yielded lesion volumes comparable to Tmax >6s and assessed the effect of reperfusion according to mismatch status, determined based on Tmax and rTTP volumes. Results: Among 102 included cases, the Tmax >6s lesion volumes corresponded most closely with rTTP >4.5s lesion volumes: median absolute difference 6.9 ml (IQR: 2.3-13.0). There was 94% agreement in mismatch classification between Tmax and rTTP-based criteria. When mismatch was assessed by Tmax criteria, the odds ratio (OR) for favorable clinical response associated with reperfusion was 7.4 (95% CI 2.3-24.1) in patients with mismatch vs. 0.4 (95% CI 0.1-2.6) in patients without mismatch. When mismatch was assessed with rTTP criteria these ORs were 7.2 (95% CI 2.3-22.2) and 0.3 (95% CI 0.1-2.2) respectively. Conclusions: rTTP yields lesion volumes that are comparable to Tmax and reliably identifies the PWI/DWI mismatch profile. Since rTTP is void of the problems associated with AIF selection, it is a suitable substitute for Tmax that could improve the robustness and reproducibility of mismatch classification in acute stroke.

30 September 2021 in Stroke
Verified
Journal Article
Closed access
PDF file
AWAnke Wouters
Anke Wouters
DRDavid Robben
David Robben
SCSoren Christensen
Soren Christensen
HMHenk A. Marquering
Henk A. Marquering
YRYvo B.W.E.M. Roos
Yvo B.W.E.M. Roos
RLRobin Lemmens
Robin Lemmens
Background and Purpose: Computed tomography perfusion imaging allows estimation of tissue status in patients with acute ischemic stroke. We aimed to improve prediction of the final infarct and individual infarct growth rates using a deep learning approach. Methods: We trained a deep neural network to predict the final infarct volume in patients with acute stroke presenting with large vessel occlusions based on the native computed tomography perfusion images, time to reperfusion and reperfusion status in a derivation cohort (MR CLEAN trial [Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands]). The model was internally validated in a 5-fold cross-validation and externally in an independent dataset (CRISP study [CT Perfusion to Predict Response to Recanalization in Ischemic Stroke Project]). We calculated the mean absolute difference between the predictions of the deep learning model and the final infarct volume versus the mean absolute difference between computed tomography perfusion imaging processing by RAPID software (iSchemaView, Menlo Park, CA) and the final infarct volume. Next, we determined infarct growth rates for every patient. Results: We included 127 patients from the MR CLEAN (derivation) and 101 patients of the CRISP study (validation). The deep learning model improved final infarct volume prediction compared with the RAPID software in both the derivation, mean absolute difference 34.5 versus 52.4 mL, and validation cohort, 41.2 versus 52.4 mL ( P <0.01). We obtained individual infarct growth rates enabling the estimation of final infarct volume based on time and grade of reperfusion. Conclusions: We validated a deep learning-based method which improved final infarct volume estimations compared with classic computed tomography perfusion imaging processing. In addition, the deep learning model predicted individual infarct growth rates which could enable the introduction of tissue clocks during the management of acute stroke.

1 August 2023 in Stroke
Verified
Journal Article
Closed access
PSPierre Seners
Pierre Seners
AWAnke Wouters
Anke Wouters
BMBenjamin Maïer
Benjamin Maïer
WBWilliam Boisseau
William Boisseau
BGBenjamin Gory
Benjamin Gory
OPOn Behalf Of Precise-Stroke-Network
On Behalf Of Precise-Stroke-Network
Currently most acute ischemic stroke patients presenting with a large vessel occlusion are treated with endovascular therapy (EVT), which results in high rates of successful recanalization. Despite this success, more than half of EVT-treated patients are significantly disabled 3 months later partly due to the occurrence of post-EVT intracerebral hemorrhage. Predicting post-EVT intracerebral hemorrhage is important for individualizing treatment strategies in clinical practice (eg, safe initiation of early antithrombotic therapies), as well as in selecting the optimal candidates for clinical trials that aim to reduce this deleterious outcome. Emerging data suggest that brain and vascular imaging biomarkers may be particularly relevant since they provide insights into the ongoing acute stroke pathophysiology. In this review/perspective, we summarize the accumulating literature on the role of cerebrovascular imaging biomarkers in predicting post-EVT–associated intracerebral hemorrhage. We focus on imaging acquired before EVT, during the EVT procedure, and in the early post-EVT time frames when new therapeutic therapies could be tested. Accounting for the complex pathophysiology of post-EVT–associated intracerebral hemorrhage, this review may provide some guidance for future prospective observational or therapeutic studies.

1 November 2019 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
BSBart Swinnen
Bart Swinnen
VSVeroniek Saegeman
Veroniek Saegeman
KBKurt Beuselinck
Kurt Beuselinck
AWAnke Wouters
Anke Wouters
GCGert Cypers
Gert Cypers
MSMaarten Schrooten
Maarten Schrooten